BioSpace News Archive

E Ink Holdings, “E Ink” (8069.TW), the leading innovator of electronic ink technology, and RyPax Wing Fat Inc., “RyPax”, the pioneering molded fiber packaging specialist, announced today that they will be showing smart and sustainable packaging prototypes for pharmaceutical applications at the AIPIA World Congress, taking place November 18-19 at the Amsterdam Conference Centre Beurs van Berlage in Amsterdam, Netherlands.

Her Excellency the Right Honourable Julie Payette, Governor General of Canada, will invest 3 Companions, 5 Officers and 31 Members into the Order of Canada during a ceremony at Rideau Hall, on Thursday, November 21, 2019, at 10:30 a.m.

BBK Worldwide, the patient experience, recruitment, and engagement leader, announces the hiring of Veronica Moore as Account Specialist.

Prices of medical care are too often unknown until the patient receives the bill after the fact, so the Association of American Physicians and Surgeons thanks the Trump Administration for rules issued last week to help shine some sunlight on the secret prices that hospitals and health plans try to keep hidden from patients.

The INRC has tripled in size over the past year and now has more than 75 organizations, spanning leading universities around the world, government labs, neuromorphic startup companies, and now several Fortune Global 500 members.

MDCN Technologies just launched NeoRhythm - a breakthrough wearable in brain science that can help people sleep better, de-stress and improve focus with this next-generation neurostimulation headband.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) was honored by the California Life Sciences Association (CLSA) with the Pantheon 2019 DiNA™ Deal of the Year Award.

FDA Approval Offers New Prospects for Parents, Children and Medical Professionals; Will Become the First and Only Product of its Kind Available in the U.S.

Propanc Developing Backup Synthetic Compound to Lead Product Candidate, PRP

Dr. Tanzi stated “I am excited about being able to work with JOT to bring drugs to patients who need solutions for neurological diseases.”